[Treatment of angina pectoris with calcium antagonists].
D000787:Angina Pectoris / Q000175:diagnosis / Q000188:drug therapy* / Q000209:etiology; D002121:Calcium Channel Blockers / Q000627:therapeutic use*; D003327:Coronary Disease / Q000150:complications; D004110:Diltiazem / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005080:Exercise Test; D005275:Fendiline / Q000627:therapeutic use; D006801:Humans; D009529:Nicardipine; D009543:Nifedipine / Q000031:analogs & derivatives / Q000627:therapeutic use; D010480:Perhexiline / Q000627:therapeutic use; D011299:Prenylamine / Q000627:therapeutic use; D011405:Propafenone / Q000031:analogs & derivatives*; D011427:Propiophenones / Q000627:therapeutic use; D014700:Verapamil / Q000031:analogs & derivatives / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D011427:Propiophenones; C001162:etafenone; D011405:Propafenone; D014700:Verapamil; D009529:Nicardipine; D004110:Diltiazem; D009543:Nifedipine; D011299:Prenylamine; D010480:Perhexiline; D005275:Fendiline
Therapie der Angina pectoris mit Calcium-Antagonisten.